Benjamin J Griffiths, Michael J R Desborough, Marjolijn Duijvestein, Geert R A D'Haens, Yuhong Yuan, Robert V Bryant, Nicola Curry, Simon P L Travis, Vipul Jairath
{"title":"Hypercoagulation after Hospital Discharge in Acute Severe Ulcerative Colitis: A Prospective Study.","authors":"Benjamin J Griffiths, Michael J R Desborough, Marjolijn Duijvestein, Geert R A D'Haens, Yuhong Yuan, Robert V Bryant, Nicola Curry, Simon P L Travis, Vipul Jairath","doi":"10.1016/j.cgh.2024.10.031","DOIUrl":null,"url":null,"abstract":"<p><strong>Background & aims: </strong>Venous thromboembolism is a serious complication during and following hospitalization with acute severe ulcerative colitis (ASUC). We evaluated serial thrombotic profiles of patients with ASUC from the point of hospitalization up to 12 weeks post-discharge and compared these with control patients with quiescent UC.</p><p><strong>Methods: </strong>Twenty-seven patients with ASUC and 25 control patients with quiescent ulcerative colitis (UC) were recruited. Thrombin generation (endogenous thrombin potential), rotational thromboelastometry (EXTEM and FIBTEM maximum clot firmness), pro-coagulant factors, anti-coagulant factors and fibrinolytic markers were assessed for those with ASUC on admission (day 1), day 5, 4 weeks and at 8 to 12 weeks. These assessments were performed on a single occasion for control patients.</p><p><strong>Results: </strong>Endogenous thrombin potential and maximum clot firmness were significantly elevated in patients with ASUC compared to controls and remained significantly elevated for 4 weeks and for 8 to 12 weeks after admission (P< 0.05), respectively. Von Willebrand Factor (VWF) antigen, factor VIII, Clauss fibrinogen concentration and platelet count were significantly increased from presentation to 8 to 12 weeks and are likely to account for changes in the global haemostatic profile.</p><p><strong>Conclusions: </strong>Global measures of haemostasis demonstrated that patients with ASUC were pro-thrombotic compared to controls with quiescent colitis. This difference was maintained 8 to 12 weeks after the initial presentation, supporting clinical observations that patients with ASUC have an elevated risk of VTE after hospital discharge.</p>","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cgh.2024.10.031","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background & aims: Venous thromboembolism is a serious complication during and following hospitalization with acute severe ulcerative colitis (ASUC). We evaluated serial thrombotic profiles of patients with ASUC from the point of hospitalization up to 12 weeks post-discharge and compared these with control patients with quiescent UC.
Methods: Twenty-seven patients with ASUC and 25 control patients with quiescent ulcerative colitis (UC) were recruited. Thrombin generation (endogenous thrombin potential), rotational thromboelastometry (EXTEM and FIBTEM maximum clot firmness), pro-coagulant factors, anti-coagulant factors and fibrinolytic markers were assessed for those with ASUC on admission (day 1), day 5, 4 weeks and at 8 to 12 weeks. These assessments were performed on a single occasion for control patients.
Results: Endogenous thrombin potential and maximum clot firmness were significantly elevated in patients with ASUC compared to controls and remained significantly elevated for 4 weeks and for 8 to 12 weeks after admission (P< 0.05), respectively. Von Willebrand Factor (VWF) antigen, factor VIII, Clauss fibrinogen concentration and platelet count were significantly increased from presentation to 8 to 12 weeks and are likely to account for changes in the global haemostatic profile.
Conclusions: Global measures of haemostasis demonstrated that patients with ASUC were pro-thrombotic compared to controls with quiescent colitis. This difference was maintained 8 to 12 weeks after the initial presentation, supporting clinical observations that patients with ASUC have an elevated risk of VTE after hospital discharge.
期刊介绍:
Clinical Gastroenterology and Hepatology (CGH) is dedicated to offering readers a comprehensive exploration of themes in clinical gastroenterology and hepatology. Encompassing diagnostic, endoscopic, interventional, and therapeutic advances, the journal covers areas such as cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion.
As a peer-reviewed publication, CGH features original articles and scholarly reviews, ensuring immediate relevance to the practice of gastroenterology and hepatology. Beyond peer-reviewed content, the journal includes invited key reviews and articles on endoscopy/practice-based technology, health-care policy, and practice management. Multimedia elements, including images, video abstracts, and podcasts, enhance the reader's experience. CGH remains actively engaged with its audience through updates and commentary shared via platforms such as Facebook and Twitter.